Question 1

What is the catalog number for RelA-associated inhibitor (PPP1R13L) Antibody (FITC)?

Accepted Answer

The catalog number for RelA-associated inhibitor (PPP1R13L) Antibody (FITC) is abx348533.

Question 2

What sizes are available for RelA-associated inhibitor (PPP1R13L) Antibody (FITC)?

Accepted Answer

RelA-associated inhibitor (PPP1R13L) Antibody (FITC) is available in the following size(s): 50 µL, 100 µL, 200 µL, 1 mL.

Question 3

How many pack sizes does RelA-associated inhibitor (PPP1R13L) Antibody (FITC) come in?

Accepted Answer

RelA-associated inhibitor (PPP1R13L) Antibody (FITC) is available in 4 different pack sizes.

Question 4

Is RelA-associated inhibitor (PPP1R13L) Antibody (FITC) in stock?

Accepted Answer

RelA-associated inhibitor (PPP1R13L) Antibody (FITC) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 7

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

RelA-associated inhibitor (PPP1R13L) Antibody (FITC)

Product Specifications

Clonality

Conjugation

Notes

Host or Source

Available Sizes

Frequently Asked Questions

Explore Other Products

CD6 (C6/372), CF405S conjugate, 0.1mg/mL

CD5 (Mantle Cell Lymphoma Marker) (CD5/2416), CF568 conjugate, 0.1mg/mL

Anti-TFF3 Antibody Picoband® (Dylight488 Conjugate)

Cytochrome p450 (M12P4H2), CF640R conjugate, 0.1mg/mL

CD73 (Immuno-Oncology Target) (NT5E/2545), CF405S conjugate, 0.1mg/mL

RET Proto-oncogene (RET/2795), CF640R conjugate, 0.1mg/mL